Management of Ewing sarcoma family of tumors: Current scenario and unmet need - Wikidata - awgldk - TriplyDB

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

http://www.wikidata.org/entity/Q28073218

about

Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing's sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therap Survival outcome among patients with Ewing's sarcoma of bones and joints: a population-based cohort study.Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma

P2860

Q33689077-3B269094-B901-4ABB-A88E-450091CA6DF3 Q47105755-A1B124CC-12B6-4186-A6C1-441EBBAB1AAD Q48363948-0E5D4E25-054B-41BD-8840-9287860446DF Q58565355-68E6281F-65D5-4D8F-B944-A6ABC7F5048C Q58697750-BDFD34B6-B3A7-4B1E-9833-B4B1FDB3E66F

P2860

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

http://www.wikidata.org/entity/Q28073218

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

@ast

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

@en

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

@nl

type

label

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

@ast

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

@en

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

@nl

prefLabel

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

@ast

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

@en

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

@nl

P1433

Q28073218-F3209975-6F38-4E17-8B02-C5C42D612ACA

P1476

Q28073218-A1D2B84D-E22D-4A06-838B-BB608C04C6CE

P2093

Q28073218-28195039-6AAC-4BAD-9168-3BD331AD3A46

Q28073218-C059127C-B136-4393-AD1B-0E0E72B858E2

P2860

Q28073218-0BB76C1C-BA33-4053-93E6-182BBE9E0CFF

Q28073218-0F10F5F3-3AAF-43A3-BC31-BE0284B2884D

Q28073218-11D4559D-DCD6-46EB-A8A5-4727CB9C0CB3

Q28073218-12603148-72E5-432C-B451-29001C09430D

Q28073218-1CBC52A3-F792-4C82-8AF6-C00BF3E8D85E

Q28073218-1CD2589D-237A-45AE-8428-E40CB6678AC4

Q28073218-21ED6BCC-6E07-4065-9CFB-C3D70E3B9C87

Q28073218-247E57D8-AD08-450F-98AC-0E9F566DE2C4

Q28073218-26EB1C6F-411C-46B1-926A-FA5BF73B089F

Q28073218-31A002A4-6534-4C90-AD15-97330C12AC18

P304

Q28073218-FEFC8BD3-697F-4F2E-A8C8-F7636C5DFE9E

P31

Q28073218-616645A6-3E11-4BA2-ABC0-5739A560B593

P3181

Q28073218-3C3324B5-7ACF-4F04-98AF-05C6854E8980

P356

Q28073218-2540110A-21FF-47FF-8171-4835E246A037

P407

Q28073218-32E14FA4-9A4D-4034-BB06-149E2AE98E6C

P433

Q28073218-77970325-2C2B-40FD-BD0B-5433456080C5

P478

Q28073218-46A32452-B706-47FE-8345-79EBC3D116D6

P577

Q28073218-4983455C-E185-4388-B673-46D0E09265F4

P698

Q28073218-D1D4D00E-FFE4-4A03-9D3F-0966091DBB0E

P932

Q28073218-008EEED1-933E-4043-9CE6-5C77563EA09E

P3181

P356

P1433

World journal of orthopedics

P1476

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

@en

P2093

Bivas Biswas

http://www.w3.org/2001/XMLSchema#string

Sameer Bakhshi

http://www.w3.org/2001/XMLSchema#string

P2860

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

Occasional involvement of the ovary in Ewing sarcoma

Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells

Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)

Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report.

Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.

Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.

Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.

Irinotecan and temozolamide treatment for relapsed Ewing sarcoma: a single-center experience and review of the literature.

Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group

P304

527-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3476402

http://www.w3.org/2001/XMLSchema#string

P356

10.5312/WJO.V7.I9.527

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27672565

http://www.w3.org/2001/XMLSchema#string

P932

5027007

http://www.w3.org/2001/XMLSchema#string